Skip to content
10-Q

Quarterly Report

Relmada Therapeutics, Inc. RLMD

0001213900-25-109983

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 73.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.19M sh
Shares Diluted Q3 2025 · Sep 30, 2025 32.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 30.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 30.16M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$31.19M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$42.96M
Short Term Investments Q3 2025 · Sep 30, 2025 $12.5M
Short Term Investments Q3 2025 · Dec 31, 2024 $41.05M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.38M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.86M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.47M
Stockholders Equity Q3 2025 · Jun 30, 2025 $15.95M
Stockholders Equity Q3 2025 · Mar 31, 2025 $22.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 $35.52M
Stockholders Equity Q3 2025 · Sep 30, 2024 $47.63M
Stockholders Equity Q3 2025 · Jun 30, 2024 $61.49M
Stockholders Equity Q3 2025 · Mar 31, 2024 $72.05M
Stockholders Equity Q3 2025 · Dec 31, 2023 $85.36M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.19M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.29M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.41M
Total Liabilities Q3 2025 · Dec 31, 2024 $10.3M
Current Assets Q3 2025 · Sep 30, 2025 $14.85M
Current Assets Q3 2025 · Dec 31, 2024 $45.8M
Total Assets Q3 2025 · Sep 30, 2025 $14.88M
Total Assets Q3 2025 · Dec 31, 2024 $45.82M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.16
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.03
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2025 −$1.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.72
Eps Basic Q3 2025 · Sep 30, 2024 −$2.03
Sga Expense Q3 2025 · Sep 30, 2025 $6.29M
Sga Expense Q3 2025 · Sep 30, 2025 $19.96M
Sga Expense Q3 2025 · Sep 30, 2024 $11.86M
Sga Expense Q3 2025 · Sep 30, 2024 $29.64M
Rd Expense Q3 2025 · Sep 30, 2025 $4.04M
Rd Expense Q3 2025 · Sep 30, 2025 $18.81M
Rd Expense Q3 2025 · Sep 30, 2024 $11.15M
Rd Expense Q3 2025 · Sep 30, 2024 $35.18M
Net Income Q3 2025 · Sep 30, 2025 −$10.09M
Net Income Q3 2025 · Sep 30, 2025 −$37.52M
Net Income Q3 2025 · Jun 30, 2025 −$9.87M
Net Income Q3 2025 · Mar 31, 2025 −$17.56M
Net Income Q3 2025 · Sep 30, 2024 −$21.73M
Net Income Q3 2025 · Sep 30, 2024 −$61.32M
Net Income Q3 2025 · Jun 30, 2024 −$17.77M
Net Income Q3 2025 · Mar 31, 2024 −$21.83M
Operating Income Q3 2025 · Sep 30, 2025 −$10.33M
Operating Income Q3 2025 · Sep 30, 2025 −$38.77M
Operating Income Q3 2025 · Sep 30, 2024 −$23.01M
Operating Income Q3 2025 · Sep 30, 2024 −$64.82M